Overview:
Attention deficit hyperactivity disorder (ADHD) is the most common neuro-developmental disorder of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, forget or loose things, daydream a lot, act without thinking about what the result will be, or may be over active. ADHD is treated with non-stimulant and stimulant drugs.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/830
Drivers:
Rising incidence of ADHD across the globe is expected to augment the growth of the global attention deficit hyperactivity disorder (ADHD) therapeutics market. For instance, according to the study published in November 2019 in JAMA Network Open, the prevalence of ADHD among adults across 7 racial and ethnic groups increased from 0.43% in 2007 to 0.96% in 2016.
Moreover, players in the market are focusing on developing a safe and effective treatment for ADHD, which in turn is also expected to boost the growth of the market. For instance, in June 2020, Otsuka Pharmaceutical announced positive top-line results from two, six-week, phase 3 clinical trials that evaluated the safety, efficacy, and tolerability of oral Centanafadine for the treatment of adult patients with ADHD.
COVID-19 Impact:
Following the outbreak of COVID-19, the World Health Organization declared the outbreak a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. According to WHO, worldwide, as of 26 November 2020, there have been more than 60.3 million confirmed cases of COVID-19.
Thus, several governments across the world are taking initiatives to tackle ADHD in children during the pandemic. For instance, according to the study published in April 17, 2020 in THE LANCET journal, the patients suffering from ADHD have become more vulnerable due to the stress caused by the pandemic.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/830
Regional Insights:
North America is expected to witness robust growth in the global attention deficit hyperactivity disorder (ADHD) therapeutics market, owing to frequent approvals and launches in the region. For instance, in March 2019, Adlon Therapeutics L.P. announced that the U.S. Food and Drug Administration (FDA) has approved Adhansia XR (methylphenidate hydrochloride) extended-release capsules CII, a central nervous system (CNS) stimulant, for the treatment of ADHD in patients six years and older.
Market Taxonomy:
By Drug Type:
- Stimulants
- Non-stimulants
By Age Group:
- Pediatric
- Adolescent
- Adult
By Distribution Channel:
- Specialty Clinics
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Competitive Landscape:
Major players active in the global attention deficit hyperactivity disorder (ADHD) therapeutics market are Purdue Pharma L.P., GlaxoSmithKline plc, Novartis International AG, American Brivision (Holding) Corporation, Neos Therapeutics, Inc., Otsuka Pharmaceutical Co., Ltd., RespireRx Pharmaceuticals Inc, Noven Pharmaceuticals, Inc, Janssen Pharmaceuticals, Inc, Eli Lilly And Company, Amneal Pharmaceuticals, Inc, and Takeda Pharmaceutical Company Limited, among others.
Reasons to Buy this Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics market
➡Leading company profiles reveal details of key Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 Flat USD2000 Off
Buy This Complete Business Report @
https://www.coherentmarketinsights.com/promo/buynow/830
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Age Group
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- Value Chain Analysis.
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, Impact of COVID-19 Pandemic
- COVID19 Epidemiology
- Government Initiatives to Combat Attention Deficit Hyperactivity Disorder (ADHD) amid COVID-19
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Drug Type, 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Amphetamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Methylphenidate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Dextroamphetamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Dexmethylphenidate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Lisdexamfetamine Dimesylate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Amphetamine
- Non-stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Atomoxetine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Bupropion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Guanfacine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Clonidine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Atomoxetine
- Stimulants
- Introduction
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Age Group, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Pediatric and Adolescent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Pediatric and Adolescent
- Introduction
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Distribution Channel, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- E-commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Specialty Clinics
- Introduction
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Region, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Countries, 2017–2027
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Age Group, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Amneal Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lilly And Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Janssen Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Noven Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- RespireRx Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Otsuka Pharmaceutical Co., Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Neos Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- American Brivision (Holding) Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Purdue Pharma L.P.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Amneal Pharmaceuticals, Inc.
- Company Profiles
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837